He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...
"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...
We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...
Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.
Fox Business on MSN
AI genome sequencing could transform rare disease diagnosis: GeneDx CEO
GeneDx CEO Katherine Stueland discusses the company’s AI-driven partnership with Komodo Health, the push to speed rare disease diagnosis and GeneDx’s accelerating growth outlook.
A UK startup aiming to solve key challenges in life sciences through AI has unveiled the “world’s first AI models for ...
Genetic testing on embryos is more sophisticated and accessible than ever—and it’s now being sold as a way to let parents pick their future baby’s best traits.
Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results